Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.

Por Schmidt, M., Wels, W.
Publicado em 1996

Immunotoxins: experimental design

Por Dall, P, Wels, W
Publicado em 2001

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes

Por Weth, R, Biburger, M, Wels, W
Publicado em 2004

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells.

Por Moritz, D, Wels, W, Mattern, J, Groner, B
Publicado em 1994

Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody-toxin specific for the EGF receptor.

Por Schmidt, M., Vakalopoulou, E., Schneider, D. W., Wels, W.
Publicado em 1997

Chimeric carrier proteins for targeted delivery of tumor antigens to professional antigen presenting cells

Por Mittrücker H-W, Kursar M, Weth R, Rohrbach F, Wels W
Publicado em 2004-07-01

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.

Por Harwerth, I. M., Wels, W., Schlegel, J., Müller, M., Hynes, N. E.
Publicado em 1993

Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct

Por Roth, A, Rohrbach, F, Weth, R, Frisch, B, Schuber, F, Wels, W S
Publicado em 2005

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins

Por Schneider, B, Münkel, S, Krippner-Heidenreich, A, Grunwald, I, Wels, W S, Wajant, H, Pfizenmaier, K, Gerspach, J
Publicado em 2010

P04.21 Combination therapy of CAR-NK cells and anti-PD-1 antibody displays potent efficacy against late-stage Glioblastoma and induces protective antitumor immunity

Por Strassheimer, F, Zhang, C, Mildenberger, I C, Harter, P N, Tonn, T, Steinbach, J P, Wels, W S, Burger, M C
Publicado no Neuro Oncol (2018)

O6.05 ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA

Por Burger, M.C., Zhang, C., Jennewein, L., Schönfeld, K., Genßler, S., Grez, M., Tonn, T., Mittelbronn, M., Steinbach, J.P., Wels, W.S.
Publicado em 2014

P04.05 The CAR2BRAIN study: a monocentric phase I trial with ErbB2-specific NK-92/5.28.z cells in recurrent glioblastoma

Por Burger, M. C., Mildenberger, I., Zhang, C., Ihrig, K., Wagner, M., Mittelbronn, M., Senft, C., Tonn, T., Wels, W. S., Steinbach, J. P.
Publicado no Neuro Oncol (2016)

P07.01 The CAR2BRAIN study: a monocentric phase I trial with ErbB2-specific NK-92/5.28.z cells in recurrent glioblastoma

Por Burger, M. C., Mildenberger, I. C., Cieplik, H. C., Zhang, C., Jennewein, L., Ihrig, K., Wagner, M., Mittelbronn, M., Senft, C., Tonn, T., Wels, W. S., Steinbach, J. P.
Publicado no Neuro Oncol (2017)